Immatics N.V. (IMTX)
NASDAQ: IMTX · IEX Real-Time Price · USD
12.52
+0.20 (1.58%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Immatics Revenue

Immatics had revenue of $80.95M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $32.90M with 208.99% year-over-year growth. In the year 2023, Immatics had annual revenue of $60.00M.

Revenue (ttm)
$80.95M
Revenue Growth
-6.58%
P/S Ratio
15.94
Revenue / Employee
$151,300
Employees
535
Market Cap
1.29B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202360.00M-123.87M-67.37%
Dec 31, 2022183.86M144.36M365.44%
Dec 31, 202139.50M1.39M3.65%
Dec 31, 202038.11M17.38M83.86%
Dec 31, 201920.73M16.40M378.37%
Dec 31, 20184.33M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Omnicell 1.10B
ANI Pharmaceuticals 517.46M
Phreesia 373.67M
Arcus Biosciences 237.00M
Ardelyx 159.11M
Establishment Labs Holdings 155.79M
Gyre Therapeutics 140.62M
Prothena Corporation 89.25M
Revenue Rankings